Latest News and Press Releases
Want to stay updated on the latest news?
-
CANDID-CNS™ is the new state-of-the-art AI model for BBB penetration: it achieves 87% AUPRC on bRo5 small molecules compared to 56% by Pfizer’s CNS MPO.CANDID-CNS™ distinguishes CNS penetrant...
-
CAMBRIDGE, Mass., March 23, 2021 (GLOBE NEWSWIRE) -- 1910 Genetics, a biotechnology company integrating artificial intelligence (AI), computation and biological automation to improve drug...